Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients

Neoplasma

Volumn 55, Issue 5, 2008, Pages 421-427

  Radojkovic, M ^a   Ristic, S ^a   Colovic, M ^b   Cemerikic Martinovic, V ^b   Radojkovic, D ^c   Krtolica, K ^d  

^a Clinical Center Dr Dragisa Misovic   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Laboratory for Molecular Genetics of Industrial Microorganisms   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Bcl 2 IgH gene rearrangement, major breakpoint region (MBR), 5 MBR, minor cluster region (MCR); Follicular lymphoma

Indexed keywords

CD20 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROTEIN BCL 2; RECOMBINANT ALPHA INTERFERON; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHROMOSOME 14; CHROMOSOME 18; DNA EXTRACTION; FEMALE; FOLLICULAR LYMPHOMA; GENE; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; IGH GENE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; SERBIA; GENETICS; IMMUNOGLOBULIN GENE; LYMPH NODE METASTASIS; METASTASIS; PROTO ONCOGENE; VASCULAR TUMOR; YUGOSLAVIA;

FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, BCL-2; GENES, IMMUNOGLOBULIN; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA, FOLLICULAR; MALE; PROGNOSIS; VASCULAR NEOPLASMS; YUGOSLAVIA;

EID: 53449086842     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. TSUJIMOTO Y, COSSMAN J, JAFFE E et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443
2. TSUJIMOTO Y, CROCE CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83: 5214-5218
3. KORSMEYER SJ. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 1992; 80: 879-886
4. BAKHSHI A, WRIGHT J, GRANINGER W et al. Mechanism of the t(14;18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners. Proc. Natl. Acad. Sci USA 1987; 84: 2396-2400
5. CLEARY ML, GALILI N, SKLAR J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp. Med. 1986; 164: 315-320
6. ALBINGER-HEGYI A, HOCHREUTENER B, ABDOU MT et al. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 2002; 160: 823-832
7. BUCHONNET G, LENAIN P, RUMINY P et al. Characterisation of Bcl-2-JH rearrangements in follicular lymphoma: PCR detection of 3′ Bcl-2 breakpoints and evidence of a new cluster. Leukemia 2000; 14: 1563-1569
8. JOHNSON A, BRUN A, DICTOR M et al. Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade: a report from southem Sweden. Ann Oncol. 1995; 6: 789-794
9. LOKE SL, PITTALUGA S, SRIVASTAVA G et al. Translocation of bcl-2 gene in non-Hodgkincs lymphomas in Hong Kong Chinese. Br.J.Haematol. 1990; 76: 65-69
10. MITANI S, AOKI N, MUZUTANI S et al. Bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin embedded tissue specimens. Jpn J Cancer Res. 1993; 84: 37-41 (Pubitemid 23068768)
11. FEDERICO M, VITOLO U, ZINZANI PL et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood 2000; 95: 783-789
12. SOLAL-CELIGNY P, ROY P, COLOMBAT P et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265 (Pubitemid 39166497)
13. The international Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N.Engl.J.Med. 1993; 329: 987-994
14. CHESON BD, HORNING SJ, COIFFIER B et al. Report of an International Workshop to standardize response criteria for non-Hodgkincs lymphomas. J Clin Oncol 1999; 17: 1244-1253
15. HARRIS NL, JAFFE ES, DIEBOLD J et al. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting- Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849
16. The non-Hodgkincs Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkincs lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-2135
17. WRIGHT DK, MANOS MM Sample preparation from paraffin-embedded tissues. In Innis MA et al, editors. A guide to methods application. Academic Press, Berkley, California, 1990: 153-158
18. DEL SAL G, MANFIOLETTI G, SCHNEIDER C. The CTAB-DNA precipitation method: A common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing. Bio Techniques 1989; 7: 514-519
19. HOSLER GA, BASH RO, BAI X et al. Development and validation of quantitive polymerase chain reaction assay to evaluate minimal residual disease for T cell acute lymphoblastic leukemia and folicular lymhoma. Am.J.Pathol. 1999; 154: 1023-1035
20. LAMBRECHTS AC, HUPKES PE, DORSSERS LCJ et al. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non Hodgkincs lymphoma. Blood 1993; 82: 2510-2516
21. ESSOP MF, MANUEL YE, CLOSE PM. Detection of the t (14;18) translocation in follicle centre cell lymphomas in South African ethnic groups usining PCR. Leukemia and Lymphoma 1999; 34: 609-613
22. ASTER JC, LONGTINE JA. Detection of BCL2 rearrangements in follicular lymphoma Am J Pathol 2002; 160: 759-763
23. BIAGI JJ, SEYMOUR JF. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 2002; 99: 4265-4275
24. LOPEZ-GUILLERMO A, CABANILLAS F, TIMOTHY I et al. Correlation of Bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 1999; 93: 3081-3087
25. WEISENBURGER DD, GASCOYNE RD, BIERMAN PJ et al. Clinical significance of the t(14;18) and BCL-2 overexpression in follicular large cell lymphoma. Leuk Lymphoma 2000; 36: 513-523
26. TURNER GE, ROSS FM, KRAJEWSKI AS. Detection of t(14;18) in British follicular lymphomas using cytogenetics, Southern blotting and polymerase chain reaction. Br J Haematol 1995; 89: 223-225
27. VAANDRAGER JW, SCHUURING E, RAAP T et al. Interphase FISH detection of Bcl2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 2000; 27: 85-94
28. SHAMINIE J, PEH SC, TAN MJ. Improvement in the detection rate of t(14;18) translocation on paraffin-embedded tissue: a combination approach using PCR and FISH. Pathology 2003; 35: 414-421
29. JOHNSON PWM, SWINBANK K, MACLENNAN S et al. Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study. Annals of Oncology 1999; 10: 1349-1354
30. KURLAND JF, KODYM R, STORY MD et al. NF-kB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. Journal of Biologica Chemistry 2001; 276: 45380-45386 (Pubitemid 37391335)
31. PAPAKONSTANTINOU G, VERBEKE C, HASTKA J et al. Bcl-2 expresion in non-Hodgkincs lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol 2001; 113: 383-390
32. SCHULER F, HIRT C, DOLKEN G. Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 2003; 13: 203-209
33. HORSMAN DE, OKAMOTO I, LUDKOVSKI O et al. Follicular lymphoma lacking the t(14;18)(q32;21): identification of two disease subtypes Br J Haematol. 2003; 120: 424-433
34. KARUBE K, GUO Y, SUZUMIYA J et al. CD10(-)MUM1(+) follicular lymphoma lacks BCL2 translocation and shows characteristic biological and clinical features. Blood 2007; 109: 3076-3079
35. IQBAL S, JENNER MJ, SUMMERS KE et al. Reliable detection of clonal IgH/Bcl-2 MBR rearrangement in follicular lymphoma: methodology and clinical significance. Br J Haematol 2004; 124: 325-328
36. MONTOTO S, LOPEZ-GUILLERMO A, COLOMER D et al. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma. Leuk Lymphoma 2003; 44. 71-76
37. SAYHAN N, TUZUNER N, AKI H et al. Detection of t(14;18) in Turkish follicular lymphomas using the polymerase chain reaction. Leuk Res 2000; 24: 475-479 (Pubitemid 30227224)
38. NORIEGA MF, DE BRASI C, NARBAITZ M et al. Incidence of bcl-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR. Blood, Cell, Molecul and Diseases 2004; 32: 232-239
39. AKASAKA T, AKASAKA H, YONETANI N et al. Refinement of the BCL-2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes, chromosomes and cancer 1998; 21: 17-29
40. BATSTONE PJ, GOODLAD JR. Efficasy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR. J Clin Pathol. 2005; 58: 81-82
41. WEINBERG OK, AI WZ, MARIAPPAN MR et al. "Minor" BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. J Mol Diagn. 2007; 9: 530-537